Introduction {#sec1}
============

Anemia is a widespread problem in many low- and middle-income countries, and remains persistent during infancy and early childhood in Indonesia. Almost 30% of preschool children in Indonesia are anemic according to the latest national data ([@bib1]), with rates even higher during infancy depending on age and geographic region ([@bib2]). Despite limited data, iron deficiency (ID) has been assumed to be the major cause of anemia in Indonesia ([@bib5]).

Increasingly, the contribution of many other coexisting factors besides ID to the overall burden of anemia in childhood is being recognized. These include multiple micronutrient deficiencies, parasitic infections, inflammation, and in some regions genetic hemoglobin (Hb) disorders ([@bib6], [@bib7]). However, to date their relative importance as predictors of Hb during infancy in Indonesia has not been investigated.

In addition to iron, other micronutrients such as folate, vitamin B-12, and vitamin A have well-established roles in normal hematopoiesis ([@bib8]). However, emerging evidence suggests that zinc, selenium, and vitamin D may also be involved through several plausible mechanisms ([@bib6], [@bib9]). Earlier studies in Indonesia have documented deficiencies of iron, vitamin A, and zinc during infancy ([@bib2], [@bib10], [@bib11]) but, to our knowledge, there are limited data for the other micronutrients.

In disadvantaged settings, when infants begin to crawl around the home and eat solid foods, they may become exposed to infective eggs of soil-transmitted helminths ([@bib12]) which, depending on the intensity of infection, have the potential to induce anemia through both blood loss ([@bib13]) and malabsorption of micronutrients ([@bib14]). Losses of micronutrients such as iron, zinc, vitamin A, and selenium can compromise the immune system, thus increasing the susceptibility of the infants to infections and inflammation. During inflammation, inflammatory cytokines initiate the acute phase response (APR), during which there are alterations in the concentrations of numerous plasma proteins regulated primarily by the liver. Protein concentrations that are increased or decreased in the plasma during the APR are classified as positive or negative acute phase proteins (APPs), respectively, and include ferritin (positive APP) and retinol-binding protein (RBP) (negative APP). As a consequence, micronutrient biomarker concentrations such as plasma ferritin are temporarily elevated, whereas others such as serum RBP are temporarily reduced during the APR, even though there is no change in micronutrient status. This leads to inaccurate assessments of micronutrient status and over- or underestimates of the prevalence of deficiency in a population during inflammation ([@bib15]). In addition, both absorption of iron and the release of iron from body stores are reduced in response to inflammation, and as a consequence functional ID may develop and, ultimately, iron deficiency anemia (IDA) ([@bib16]).

In many Southeast Asian countries, hereditary disorders affecting the structure, function, and/or production of Hb are widespread. Data on genetic Hb disorders in Indonesia are limited, although β-thalassemia, Hb E, and α-thalassemia have been reported, with ranges of carrier frequency rates of 5--10%, 1--33%, and 6--16%, respectively, depending on ethnicity ([@bib17]). Some of these genetic Hb disorders present as mild to severe anemia ([@bib18], [@bib19]), although the extent to which they contribute to low Hb concentrations in Indonesia in later infancy remains uncertain.

We previously reported on the adequacy of both complementary feeding patterns ([@bib20]) in a longitudinal study of infants from 6 to 12 mo of age living in Sumedang district, West Java, Indonesia. In addition, we applied the new Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia approach ([@bib21]) to adjust 4 micronutrient biomarkers of iron, zinc, vitamin A, and selenium for inflammation ([@bib22]). In this study, we extend our research to investigate the role of 3 additional micronutrient biomarkers---folate, vitamin B-12, and vitamin D---together with the 4 micronutrient biomarkers studied earlier ([@bib22]), as well as selected nonnutritional factors as potential predictors of Hb and anemia among these Indonesian infants. We hypothesized that low status of 6 micronutrients (folate, vitamin B-12, vitamin A, zinc, selenium, and vitamin D), in addition to iron, would be independently associated with Hb.

Methods {#sec2}
=======

Study design and participant selection {#sec2-1}
--------------------------------------

Details of the study design, selection and characteristics of the participants, and justification for the sample size based on the prevalence of stunting were described earlier ([@bib20], [@bib22]). Briefly, apparently healthy breastfed infants randomly selected from local birth registry data were recruited at age 6 mo (*n* = 230) from 30 villages in 3 subdistricts of Sumedang district, West Java, and followed-up at ages 9 mo (*n* = 202) and 12 mo (*n* = 190) from August, 2013 to August, 2014. Ethical approval of the study protocol was obtained from the Human Ethics Committees of University of Otago, New Zealand (H14/022) and the Universitas Padjadjaran, Indonesia (No 132/UN6C2.1.2/KEPK/PN/2014). Parents of the infants provided informed written consent for the study. The respondents were compensated for their transportation costs for the health clinic visits, and provided with the results from the anthropometric assessment of growth, complete blood count, and the blood group of their infants.

After recruitment, pretested questionnaires were used to collect information on sociodemographic status, health, infant and young child feeding practices, infant morbidity, history of smoking in the home, and maternal parity. Maternal height and weight and selected infant anthropometric measurements were also taken at this time, and again every 3 mo together with data on infant health, infant and young child feeding practices, and morbidity ([@bib20]).

Stool collection and assessment of parasite status {#sec2-2}
--------------------------------------------------

Stool samples were collected from the infants at 6, 9, and 12 mo of age, and transported in chilled containers to the Parasite Laboratory, Faculty of Medicine, Universitas Padjadjaran, Indonesia. The Kato Katz method ([@bib23]) was used for microscopic detection of the absence/presence of soil-transmitted helminths and the number of eggs of each of the following species: *Ascaris lumbricoides*, *Trichuris trichiura*, *Necator americanus*, and *Ancylostoma duodenale*. No examination was performed for protozoa.

Laboratory assessment {#sec2-3}
---------------------

Anticoagulated whole blood and serum from infants were collected from morning, nonfasting, venipuncture blood samples using rigorous trace element--free collection and separation procedures ([@bib24]) as reported previously ([@bib22]). Presence of symptoms of infection, time of the blood collection, and time elapsed since the last meal were recorded. Details of the analysis and quality control for complete blood count, serum ferritin, soluble transferrin receptor (sTfR), RBP, zinc, selenium, α 1-acid glycoprotein (AGP), and C-reactive protein (CRP) were reported earlier ([@bib22]). Briefly, serum ferritin, sTfR, RBP, AGP, and CRP were analyzed by a combined sandwich ELISA technique in the VitMin Laboratory of Dr. J Erhardt, Germany ([@bib25]), whereas serum zinc and selenium were assayed by inductively coupled plasma MS (Agilent 7500ce ICP-MS; Agilent Technologies) in the Centre for Trace Element Analysis, Department of Chemistry, University of Otago, New Zealand.

Serum vitamin B-12 was analyzed by an automated electrochemiluminescence immunoassay (CV = 4%) using a commercial kit in the Department of Human Nutrition, University of Otago, New Zealand (vitamin B-12 Elecsys reagent kit, Roche Diagnostics). Accuracy was checked via the manufacturer's controls and values fell within certified ranges. Serum folate was measured by a microbiological assay (CV = 14%) ([@bib26], [@bib27]), as described previously ([@bib28]). A high, medium, and low pooled quality control serum control was included on each plate (expressed as mean ± 2SD; "High" 45.5 ± 11.5 nmol/L; "Medium" 26.35 ± 5.2 nmol/L; and "Low" 15.0 ± 3.8 nmol/L) and compared with analyzed values \[expressed as mean (%relative standard deviation)\] of 49.7 nmol/L (9.7%), 30.3 nmol/L (7.3%), and 15.3 nmol/L (9.7%), respectively. Serum vitamin D (as 25-hydroxyvitamin D) at 6 and 12 mo was analyzed using isotope-dilution LC tandem MS, using an API 3200 instrument (Applied Biosystems) connected to a Dionex Ultimate 3000 HPLC system in the Department of Human Nutrition, University of Otago, New Zealand ([@bib29]). Analysis of serum 25-hydroxyvitamin D was not performed at 9 mo in view of the low proportion of infants with low concentrations at both 6 and 12 mo and financial constraints. Values for low, medium, and high serum 25-hydroxyvitamin D controls (UTAK Laboratories Inc.) fell within specified ranges, with a CV \< 5% for a pooled sample. Baseline maternal finger-prick blood samples were also collected for Hb via the HemoCue Hb 201^+^ System (HemoCue AB).

For the assay of genetic Hb disorders, RBCs were washed 3 times and divided into aliquots in cryovials for storage at −80°C, before shipment on dry ice to the Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Thailand for analysis by automated cation exchange HPLC (VARIANT II, β-thalassemia short program, Bio-Rad Laboratories) ([@bib30]).

Values for folate, vitamin D, ferritin, RBP, zinc, and selenium were each adjusted for inflammation using both CRP and AGP following the Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia regression approach ([@bib22]) in view of the reported effects of inflammation on each of these micronutrient biomarkers ([@bib31]). Anemia was defined as Hb \<110 g/L ([@bib32]), and when accompanied by either low serum ferritin (i.e., \<12 µg/L) or high sTfR (i.e., \>8.3 mg/L) was considered to reflect IDA. Storage iron depletion was defined as serum ferritin \<12 µg/L ([@bib33]); tissue iron deficiency as sTfR \>8.3 mg/L; low RBP as \<0.83 µmol/L ([@bib25]); low serum zinc as \<9.9 µmol/L ([@bib24]); low serum selenium as \<0.82 µmol/L ([@bib34]); low serum vitamin B-12 as \<150 pmol/L ([@bib35]); low serum folate as \<6.8 nmol/L ([@bib36]); and low serum 25-hydroxyvitamin D as \<50 nmol/L ([@bib37], [@bib38]).

Statistical analyses {#sec2-4}
--------------------

Data were transferred into Stata version 12 (StataCorp LP) and descriptive and comparative statistics calculated. All continuous variables were plotted and distributions visually assessed. Principal component analysis was used to derive an asset-based wealth index following the Demographic Health Survey Wealth Index guidelines ([@bib39]). Subsequently, the wealth index was divided into quintiles from the lowest to the highest household wealth. Ferritin, CRP, and AGP were log transformed before analysis. The mean ± SD or geometric mean (95% CI) for Hb, micronutrient biomarkers, and growth indicators was calculated, where appropriate at each age. To allow comparison between all 3 ages, calculations were also performed for those participants with measures at all 3 ages.

Univariate regression analysis examined the relation between Hb and all predictors using the same respondents at all ages to allow for age-related hypotheses, with the exception of soil-transmitted helminthiasis and genetic Hb disorders. There was only 1 case of *A.lumbricoides* found at 9 mo. The latter were not included because of the small number of infants identified with these disorders and the limitations of the assay method used. Consequently, helminthiasis and genetic Hb disorders were not included in the univariate regression analysis. Sensitivity analyses included all available respondents.

Household, mother, and infant predictors with *P* \< 0.250 at any time point were included in a multivariate analysis of the associations between all biomarkers and Hb. Only the iron biomarker (i.e., serum ferritin) and marker of inflammation (i.e., CRP) that explained the highest amount of the variance (*R*^2^) with Hb were included in the multivariate models to avoid issues with multicollinearity. Only the full sample data at 6 and 12 mo were used in the multivariate model to reduce the number of statistical models created, and to enable the vitamin D biomarker, not assessed at 9 mo, to be included. All variables were standardized for multivariate analysis.

Missing micronutrient biomarker values were imputed and sensitivity analyses undertaken. The number of missing values were 22 at 6 mo and 27 at 12 mo for both selenium and zinc, 36 and 32 at 6 and 12 mo for folate, respectively, 48 and 34 at 6 and 12 mo for vitamin B-12, respectively, and 35 and 27 at 6 and 12 mo for vitamin D, respectively. Imputation was performed using multivariate normal regression with an iterative Markov Chain Monte Carlo method for 20 imputations. Model assumptions were checked using residual plots. A significance level of *P* \< 0.05 was used for the multivariate models.

Results {#sec3}
=======

Of the 275 infants who were approached, 230 (83.6%) were recruited and 190 completed the study. Reasons for nonparticipation and withdrawal were described previously ([@bib20]). Blood samples were provided by all respondents, although the volume of serum obtained was insufficient for some of the assays ([@bib22]). No significant differences by sex, anthropometric, health, or socioeconomic status were found between those individuals who participated and those who were lost to follow-up.

Of the mothers, about one-third were primiparous, more than half had attended secondary school, and nearly one-third were overweight, with 6% of women classified as obese ([**Table 1**](#tbl1){ref-type="table"}). More than two-thirds of the households were exposed to smoking in the home. Mean ± SD BMI *z* score for infants decreased from 0.27 ± 1.14 at age 6 mo to 0.09 ± 1.08 at age 12 mo ([**Table 2**](#tbl2){ref-type="table"}). Additional health characteristics of the infants were reported previously ([@bib20]).

###### 

Sociodemographic maternal and infant characteristics[^1^](#tb1fn2){ref-type="table-fn"}

                                                     *n*   6 mo
  -------------------------------------------------- ----- ----------------
  Household and maternal factors                           
   Education                                         228   
    No/primary school                                      40.8
    Secondary school                                       53.1
    Tertiary school                                        6.1
   Age, y                                            225   27.5 ± 7.2
   Smoking at home                                   217   72.8
   BMI,[^2^](#tb1fn2){ref-type="table-fn"} kg/m^2^   218   
    Underweight                                            7.3
    Normal                                                 56.0
    Overweight                                             30.7
    Obese                                                  6.0
   Height \<145 cm                                   223   15.3
   Hemoglobin, g/L                                   217   132 (130, 134)
   Parity                                            223   
    1                                                      39
    2                                                      35.9
    ≥3                                                     25.1
  Infant factors                                           
   Female                                            228   55.3

Values are percentages, mean ± SD, or geometric mean (95% CI).

Classification of BMI for Asian populations ([@bib40]): \<18.5, underweight; 18.5--24.9, increasing but acceptable risk (normal); 25.0--29.9, increased risk (overweight); and ≥30.0, high risk (obese).

###### 

Infant BMI *z* scores, Hb, IDA, micronutrient biomarkers, and proportion with micronutrient deficiencies at 6, 9, and 12 mo of age with no missing values for the respondents at each age[^1^](#tb2fn1){ref-type="table-fn"}

                                           *n*   6 mo                   9 mo                   12 mo
  ---------------------------------------- ----- ---------------------- ---------------------- ----------------------
  BMI *z* score                            188   0.27 ± 1.14            0.23 ± 1.03            0.09 ± 1.08
  Hb, g/L                                  188   112.1 (110.5, 113.7)   110.4 (108.7, 112.1)   110.5 (108.7, 112.4)
  Anemia (Hb \< 110 g/L)                   188   33.5                   43.1                   38.8
  sTfR, mg/L                               166   5.8 (5.4, 6.3)         6.9 (6.4, 7.4)         7.5 (7.0, 8.0)
  Iron deficiency (sTfR \> 8.3 mg/L)       166   16.3                   29.5                   38.0
  IDA based on sTfR                        166   14.1                   23.5                   23.4
  Ferritin, µg/L                           166   24.1 (21.1, 27.4)      13.0 (11.6, 14.7)      8.6 (7.7, 9.6)
  Iron deficiency (ferritin \< 12 µg/L)    166   23.5                   45.8                   66.9
  IDA based on ferritin                    166   16.0                   32.6                   36.4
  RBP, µmol/L                              166   1.00 (0.98, 1.04)      1.07 (1.03, 1.10)      1.07 (1.03, 1.10)
  RBP deficiency (\<0.83 µmol/L)           166   18.1                   8.4                    13.2
  Zinc, µmol/L                             103   12.0 (11.5, 12.5)      11.3 (11.0, 11.6)      11.8 (11.5, 12.2)
  Zinc deficiency (\<9.9 µmol/L)           103   13.6                   17.5                   9.7
  Selenium, µmol/L                         103   0.73 (0.70, 0.75)      0.77 (0.74, 0.79)      0.82 (0.80, 0.85)
  Selenium deficiency                      103   76.7                   60.2                   47.6
  Vitamin B-12, pmol/L                     86    244.3 (217.4, 274.4)   260.1 (233.2, 290.2)   286.3 (236.8, 263.1)
  Vitamin B-12 deficiency (\<150 pmol/L)   86    17.4                   11.6                   9.3
  Folate, nmol/L                           90    48.8 (45.5, 52.4)      49.8 (46.6, 53.2)      50.2 (47.2, 53.4)
  Folate deficiency (\<6.8 nmol/L)         90    0.0                    0.0                    0.0
  Vitamin D, nmol/L                        116   89.7 (85.8, 93.8)      N/A                    83.2 (79.5, 87.1)
  Vitamin D deficiency (\<50 nmol/L)       116   0.9                    N/A                    4.3

Values are percentages, mean ± SD, or geometric mean (95% CI). Hb, hemoglobin; IDA, iron deficiency anemia; N/A, not available; RBP, retinol-binding protein.

Prevalence of anemia was highest at age 9 mo (43.1%), whereas that of IDA was highest at age 12 mo (23.4% and 36.4% based on sTfR and ferritin, respectively). Serum micronutrient biomarker data at each age are presented in [Table 2](#tbl2){ref-type="table"} for participants with measures at all 3 ages; complete data are presented in **SupplementalTable 1**. There were no significant differences between concentrations of serum vitamin D and folate before and after adjustment for inflammation. Serum vitamin D increased after adjustment for inflammation from 85.8 to 93.8 nmol/L at 6 mo and from 79.5 to 87.1 nmol/L at 12 mo. Serum folate increased after adjustment at 6, 9, and 12 mo from 45.5 to 52.4 nmol/L, 46.6 to 53.2 nmol/L, and 47.2 to 53.4 nmol/L, respectively.

Geometric mean concentrations for all the micronutrient biomarkers varied across the 3 age groups, although the differences were nonsignificant, with the exception of ferritin which decreased significantly from age 6 to 12 mo (*P* \< 0.001). Very few infants or none had low concentrations of serum vitamin D (\<50 nmol/L) or folate (\<6.8 nmol/L), regardless of age, whereas the prevalence of low serum vitamin B-12, RBP, and zinc was between 13.6% and 18.1% at 6 mo, 8.4% and 17.5% at 9 mo, and 9.3% and 13.2% at 12 mo, respectively. Of the micronutrients, serum selenium had the highest prevalence of low values across all ages, followed by ferritin, indicative of depleted iron stores ([@bib22]).

Only 17.2% of the children at age 6 mo and 10.0% at age 12 mo had no evidence of micronutrient deficiencies. Instead, nearly 50% of the infants (42--43%) had 1 micronutrient deficiency, most frequently iron, and about one-third (28--31%) had 2 micronutrient deficiencies at some time point during the study. The number of nonanemic infants with β-thalassemia, Hb E with α-thalassemia, Hb H, and α-thalassemia was 4, 2, 1, and 14, respectively.

Predictors of Hb and anemia {#sec3-1}
---------------------------

In the univariate model, maternal height was associated with both Hb and anemia at ages 6 and 9 mo, but only with anemia at 12 mo, whereas infant CRP was significant for Hb and anemia at 6 mo ([**Tables3**](#tbl3){ref-type="table"} and [**4**](#tbl4){ref-type="table"}). Ferritin and being female were positively associated with Hb and negatively associated with anemia and sTfR was negatively associated with Hb and positively associated with anemia across all ages. RBP was positively associated with Hb and inversely related to anemia at 9 and 12 mo.

###### 

Univariate associations with Hb at ages 6, 9, and 12 mo with no missing values for the respondents at each age[^1^](#tb3fn1){ref-type="table-fn"}

                                         6 mo                    9 mo                                         12 mo                                                                                    
  -------------------------------- ----- ----------------------- -------------------------------------------- ---------------------- ------------------------------------------ ---------------------- ------------------------------------------
  Household and maternal factors                                                                                                                                                                       
   Wealth index (quintiles)        183   −0.11 (−1.31, 1.10)     0.860                                        0.95 (−0.21, 2.10)     0.108[^2^](#tb3fn2){ref-type="table-fn"}   0.55 (−0.74, 1.84)     0.403
   Education                       188                                                                                                                                                                 
    No/primary school                    Reference                                                            Reference                                                         Reference              
    Secondary school                     1.93 (−1.34, 5.20)      0.246[^2^](#tb3fn2){ref-type="table-fn"}     0.46 (−3.05, 3.97)     0.796                                      −0.05 (−3.79, 3.70)    0.980
    Tertiary school                      5.04 (−1.34, 11.43)     0.121[^2^](#tb3fn2){ref-type="table-fn"}     6.57 (1.29, 11.85)     0.015[^2^](#tb3fn2){ref-type="table-fn"}   4.47 (−3.20, 12.15)    0.252
   Maternal age, y                 185   −0.08 (−0.28, 0.12)     0.431                                        0.06 (−0.14, 0.27)     0.542                                      0.11 (−0.13, 0.34)     0.362
   Smoking at home                 179   −0.86 (−4.28, 2.55)     0.619                                        1.58 (−1.98, 5.15)     0.382                                      0.06 (−3.94, 4.05)     0.977
   Maternal BMI, kg/m^2^           180   0.05 (−0.39, 0.48)      0.828                                        0.16 (−0.30, 0.63)     0.486                                      0.00 (−0.46, 0.45)     0.988
   Maternal height, cm             185   −0.44 (−0.72, −0.17)    0.002[^2^](#tb3fn2){ref-type="table-fn"}     −0.36 (−0.68, −0.03)   0.031[^2^](#tb3fn2){ref-type="table-fn"}   −0.20 (−0.54, 0.14)    0.246[^2^](#tb3fn2){ref-type="table-fn"}
   Maternal Hb, g/L                178   0.09 (−0.02, 0.20)      0.128[^2^](#tb3fn2){ref-type="table-fn"}     0.09 (−0.02, 0.20)     0.099[^2^](#tb3fn2){ref-type="table-fn"}   0.06 (−0.06, 0.19)     0.337
   Parity                          183   −0.56 (−1.87, 0.75)     0.399                                        0.84 (−0.48, 2.16)     0.212[^2^](#tb3fn2){ref-type="table-fn"}   0.87 (−0.50, 2.23)     0.211[^2^](#tb3fn2){ref-type="table-fn"}
   ln(CRP), ln(mg/L)               166   −1.00 (−1.77, −0.23)    0.011[^2^](#tb3fn2){ref-type="table-fn"}     −0.77 (−1.75, 0.21)    0.125[^2^](#tb3fn2){ref-type="table-fn"}   −0.46 (−1.53, 0.60)    0.392
   ln(AGP), ln(g/L)                166   −2.81 (−5.45, −0.17)    0.037[^2^](#tb3fn2){ref-type="table-fn"}     −1.43 (−4.49, 1.63)    0.357                                      −1.16 (−4.23, 1.91)    0.456
   Infant sex (female vs. male)    188   7.88 (4.96, 10.79)      \<0.001[^2^](#tb3fn2){ref-type="table-fn"}   5.83 (2.58, 9.08)      0.001[^2^](#tb3fn2){ref-type="table-fn"}   5.49 (1.95, 9.03)      0.003[^2^](#tb3fn2){ref-type="table-fn"}
   BMI *z* score                   188   −0.02 (−1.36, 1.32)     0.977                                        0.87 (−0.76, 2.49)     0.292                                      −0.33 (−2.10, 1.44)    0.713
  Biomarkers                                                                                                                                                                                           
   Folate, nmol/L                  90    0.10 (−0.02, 0.23)      0.100                                        −0.02 (−0.18, 0.14)    0.797                                      0.04 (−0.14, 0.21)     0.668
   Vitamin B-12, pmol/L            84    0.00 (−0.01, 0.01)      0.530                                        0.01 (−0.00, 0.02)     0.243                                      0.00 (−0.02, 0.02)     0.825
   Vitamin D, nmol/L               116   0.05 (−0.03, 0.13)      0.263                                        N/A                    N/A                                        0.06 (−0.02, 0.13)     0.168
   ln(Ferritin), ln(µg/L)          166   4.74 (2.83, 6.65)       \<0.001                                      7.10 (4.97, 9.22)      \<0.001                                    8.34 (5.80, 10.89)     \<0.001
   sTfR, mg/L                      166   −1.38 (−1.96, −0.81)    \<0.001                                      −1.25 (−1.71, −0.78)   \<0.001                                    −1.27 (−1.74, −0.81)   \<0.001
   RBP, µmol/L                     166   6.23 (−0.36, 12.81)     0.064                                        14.36 (5.91, 22.80)    0.001                                      15.47 (7.83, 23.12)    \<0.001
   Zinc, µmol/L                    103   0.10 (−0.41, 0.61)      0.696                                        −0.44 (−2.10, 1.23)    0.606                                      −0.31 (−1.35, 0.72)    0.551
   Selenium, µmol/L                103   −1.66 (−18.61, 15.29)   0.846                                        4.16 (−14.16, 22.49)   0.653                                      −7.82 (−22.49, 6.84)   0.292

AGP, α 1-acid glycoprotein; CRP, C-reactive protein; Hb, hemoglobin; ln, log-transformed; N/A, not available; RBP, retinol-binding protein; sTfR, serum soluble transferrin receptor.

*P* \< 0.250 for household and maternal factors.

###### 

Univariate associations with anemia at ages 6, 9, and 12 mo with no missing values for the respondents at each age[^1^](#tb4fn1){ref-type="table-fn"}

                                         6 mo                  9 mo                                         12 mo                                                                               
  -------------------------------- ----- --------------------- -------------------------------------------- ------------------- ------------------------------------------ -------------------- ------------------------------------------
  Household and maternal factors                                                                                                                                                                
   Wealth index (quintiles)        183   0.92 (0.74, 1.15)     0.479                                        0.90 (0.73, 1.11)   0.332                                      1.01 (0.82, 1.25)    0.930
   Maternal education              188                                                                                                                                                          
    No/primary school                    Reference                                                          Reference                                                      Reference            
    Secondary school                     0.70 (0.37, 1.31)     0.262                                        1.13 (0.62, 2.06)   0.688                                      1.15 (0.62, 2.11)    0.663
    Tertiary school                      0.28 (0.06, 1.35)     0.112[^2^](#tb4fn2){ref-type="table-fn"}     0.24 (0.05, 1.14)   0.073                                      0.49 (0.12, 1.91)    0.302
   Age, y                          185   1.00 (0.96, 1.04)     0.937                                        1.00 (0.96, 1.04)   0.896                                      0.99 (0.95, 1.03)    0.663
   Smoking at home                 179   1.47 (0.71, 3.04)     0.304                                        0.87 (0.45, 1.69)   0.685                                      0.99 (0.50, 1.94)    0.969
   Maternal BMI, kg/m^2^           180   0.99 (0.92, 1.07)     0.842                                        0.97 (0.90, 1.05)   0.473                                      1.02 (0.95, 1.10)    0.611
   Maternal height, cm             185   1.05 (1.04, 1.17)     0.002[^2^](#tb4fn2){ref-type="table-fn"}     1.07 (1.01, 1.13)   0.023[^2^](#tb4fn2){ref-type="table-fn"}   1.06 (1.00, 1.13)    0.040[^2^](#tb4fn2){ref-type="table-fn"}
   Maternal hemoglobin, g/L        178   0.99 (0.99, 1.01)     0.443                                        0.99 (0.97, 1.01)   0.348                                      0.98 (0.95, 1.00)    0.029[^2^](#tb4fn2){ref-type="table-fn"}
   Parity                          183   0.94 (0.71, 1.26)     0.695                                        0.80 (0.60, 1.07)   0.131[^2^](#tb4fn2){ref-type="table-fn"}   0.83 (0.63, 1.11)    0.215[^2^](#tb4fn2){ref-type="table-fn"}
   ln(CRP), ln(mg/L)               166   1.22 (1.01, 1.47)     0.038[^2^](#tb4fn2){ref-type="table-fn"}     1.12 (0.94, 1.33)   0.208[^2^](#tb4fn2){ref-type="table-fn"}   1.04 (0.88, 1.23)    0.635
   ln(AGP), ln(g/L)                166   1.42 (0.81, 2.50)     0.222[^2^](#tb4fn2){ref-type="table-fn"}     1.45 (0.85, 2.48)   0.169[^2^](#tb4fn2){ref-type="table-fn"}   1.24 (0.75, 2.06)    0.398
   Infant sex (female vs. male)    188   0.24 (0.13, 0.46)     \<0.001[^2^](#tb4fn2){ref-type="table-fn"}   0.50 (0.28, 0.90)   0.021[^2^](#tb4fn2){ref-type="table-fn"}   0.45 (0.25, 0.82)    0.009[^2^](#tb4fn2){ref-type="table-fn"}
   BMI *z* score                   188   0.98 (0.75, 1.28)     0.874                                        0.80 (0.60, 1.06)   0.124[^2^](#tb4fn2){ref-type="table-fn"}   1.04 (0.79, 1.37)    0.769
  Biomarkers                                                                                                                                                                                    
   Folate, nmol/L                  90    0.98 (0.96, 1.01)     0.251                                        1.00 (0.98, 1.04)   0.549                                      0.96 (0.93, 1.00)    0.028
   Vitamin B-12, pmol/L            84    1.00 (1.00, 1.00)     0.861                                        1.00 (1.00, 1.00)   0.383                                      1.00 (1.00, 1.00)    0.429
   Vitamin D, nmol/L               117   0.99 (0.98, 1.01)     0.498                                        N/A                 N/A                                        0.99 (0.97, 1.01)    0.216
   ln(Ferritin), ln(µg/L)          166   0.47 (0.31, 0.71)     \<0.001                                      0.41 (0.26, 0.65)   \<0.001                                    0.27 (0.16, 0.47)    \<0.001
   sTfR, mg/L                      166   1.26 (1.11, 1.44)     \<0.001                                      1.14 (1.04, 1.24)   0.004                                      1.16 (1.06, 1.27)    0.001
   RBP, µmol/L                     166   0.36 (0.08, 1.68)     0.192                                        0.13 (0.03, 0.56)   0.007                                      0.21 (0.05, 0.90)    0.036
   Zinc, µmol/L                    103   0.99 (0.86, 1.13)     0.854                                        1.18 (0.90, 1.55)   0.225                                      0.99 (0.80, 1.23)    0.950
   Selenium, µmol/L                103   4.30 (0.12, 158.78)   0.429                                        0.11 (0.00, 2.53)   0.165                                      2.13 (0.10, 47.20)   0.633

AGP, α 1-acid glycoprotein; CRP, C-reactive protein; ln, log-transformed; N/A, not available; RBP, retinol-binding protein; sTfR, serum soluble transferrin receptor.

*P* \< 0.250 for household and maternal factors.

In the multiple regression model, ferritin, tertiary education, higher maternal Hb, lower CRP concentrations, and being female were significantly and positively associated with Hb at 6 mo, whereas only ferritin and RBP were significant and positive predictors of Hb at 12 mo ([**Table 5**](#tbl5){ref-type="table"}). The sensitivity analyses that were undertaken with imputed missing data showed no meaningful differences in associations compared with the original models. The final regression models without imputations for infants at ages 6 and 12 mo explained 37.1% and 35.3% of the variance in Hb, respectively.

###### 

Multivariate associations with infant Hb at 6 and 12 mo of age[^1^](#tb5fn1){ref-type="table-fn"}

  Variable, unit              Mean difference in Hb (g/L) per 1-SD increase (95% CI)   *P* value
  --------------------------- -------------------------------------------------------- -----------
  6 mo (*n* = 201)                                                                     
   Serum folate, nmol/L       1.53 (−0.52, 3.57)                                       0.141
   Vitamin D, nmol/L          0.61 (−0.87, 2.07)                                       0.412
   ln(Ferritin), ln(µg/L)     3.15 (1.48, 4.83)                                        \<0.001
   RBP, µmol/L                1.18 (−0.20, 2.57)                                       0.093
   Zinc, µmol/L               0.23 (−1.75, 2.22)                                       0.818
   Selenium, µmol/L           −0.67 (−2.61, 1.26)                                      0.493
   Vitamin B-12, pmol/L       0.50 (−1.30, 2.30)                                       0.582
   Wealth index (quintiles)   −0.76 (−1.86, 0.33)                                      0.171
   Maternal education                                                                  
    No/primary school         Reference                                                
    Secondary school          2.33 (−0.90, 5.57)                                       0.156
    Tertiary school           6.64 (0.62, 12.66)                                       0.031
   Maternal height, cm        −0.21 (−0.46, 0.04)                                      0.103
   Maternal Hb, g/L           0.09 (0.00, 0.18)                                        0.046
   ln(CRP), ln(mg/L)          −1.30 (−1.97, −0.63)                                     \<0.001
   Sex (female vs. male)      4.98 (1.96, 7.99)                                        0.001
   Parity                     −0.30 (−1.76, 1.15)                                      0.682
  12 mo (*n* = 169)                                                                    
   Serum folate, nmol/L       2.06 (−0.81, 4.93)                                       0.156
   Vitamin D, nmol/L          0.47 (−1.79, 2.74)                                       0.678
   ln(Ferritin), ln(µg/L)     4.38 (2.67, 6.09)                                        \<0.001
   RBP, µmol/L                1.66 (0.12, 3.19)                                        0.035
   Zinc, µmol/L               0.82 (−1.49, 3.14)                                       0.359
   Selenium, µmol/L           −0.01 (−2.53, 2.51)                                      0.995
   Vitamin B-12, pmol/L       1.13 (−1.60, 3.87)                                       0.410
   Wealth index (quintiles)   0.35 (−0.89, 1.59)                                       0.580
   Maternal education                                                                  
    No/primary school         Reference                                                
    Secondary school          −1.12 (−4.97, 2.73)                                      0.567
    Tertiary school           0.86 (−7.96, 9.68)                                       0.848
   Maternal height, cm        −0.11 (−0.46, 0.24)                                      0.522
   Maternal Hb, g/L           −0.00 (−0.12, 0.13)                                      0.997
   ln(CRP), ln(mg/L)          −0.52 (−1.60, 0.52)                                      0.322
   Sex (female vs. male)      2.44 (−1.09, 5.99)                                       0.175
   Parity                     −0.12 (−1.71, 1.48)                                      0.883

CRP, C-reactive protein; Hb, hemoglobin; ln, log-transformed; RBP, retinol-binding protein.

The potential predictors for anemia at 6 mo were similar to those reported for low Hb at 6 mo (i.e., ferritin, having a higher CRP concentration, and being male), with the exception of maternal education and the addition of a greater maternal height ([**Table 6**](#tbl6){ref-type="table"}). At 12 mo, low concentration of serum ferritin was the only significant independent predictor of anemia.

###### 

Multivariate associations with infant anemia at 6 and 12 mo of age[^1^](#tb6fn1){ref-type="table-fn"}

  Variable, unit              OR (95% CI)         *P* value
  --------------------------- ------------------- -----------
  6 mo (*n* = 201)                                
   Serum folate, nmol/L       0.87 (0.50, 1.49)   0.603
   Vitamin D, nmol/L          0.90 (0.61, 1.34)   0.613
   ln(Ferritin), ln(µg/L)     0.62 (0.42, 0.90)   0.012
   RBP, µmol/L                0.85 (0.58, 1.25)   0.407
   Zinc, µmol/L               1.21 (0.70, 2.09)   0.499
   Selenium, µmol/L           1.02 (0.68, 1.55)   0.913
   Vitamin B-12, pmol/L       1.00 (0.62, 1.61)   0.992
   Wealth index (quintiles)   1.08 (0.82, 1.40)   0.596
   Maternal education                             
    No/primary school         Reference           
    Secondary school          0.68 (0.31, 1.49)   0.333
    Tertiary school           0.19 (0.03, 1.24)   0.083
   Maternal height, cm        1.07 (1.00, 1.15)   0.036
   Maternal hemoglobin, g/L   0.99 (0.97, 1.02)   0.661
   ln(CRP), ln(mg/L)          1.25 (1.02, 1.53)   0.036
   Sex (female vs. male)      0.30 (0.14, 0.61)   0.001
   Parity                     0.84 (0.58, 1.19)   0.323
   BMI *z* score              0.85 (0.63, 1.15)   0.290
  12 mo (*n* = 169)                               
   Serum folate, nmol/L       0.57 (0.31, 1.03)   0.064
   Vitamin D, nmol/L          0.78 (0.49, 1.23)   0.284
   ln(Ferritin), ln(µg/L)     0.45 (0.30, 0.69)   \<0.001
   RBP, µmol/L                0.83 (0.58, 1.20)   0.328
   Zinc, µmol/L               0.90 (0.51, 1.56)   0.697
   Selenium, µmol/L           0.90 (0.52, 1.55)   0.700
   Vitamin B-12, pmol/L       0.99 (0.59, 1.66)   0.960
   Wealth index (quintiles)   1.10 (0.81, 1.49)   0.548
   Maternal education                             
    No/primary school         Reference           
    Secondary school          0.89 (0.37, 2.16)   0.796
    Tertiary school           0.44 (0.07, 2.94)   0.399
   Maternal height, cm        1.05 (0.98, 1.13)   0.195
   Maternal hemoglobin, g/L   0.98 (0.95, 1.01)   0.192
   ln(CRP), ln(mg/L)          1.04 (0.84, 1.28)   0.739
   Sex (female vs. male)      0.73 (0.33, 1.61)   0.441
   Parity                     0.79 (0.53, 1.18)   0.253
   BMI *z* score              0.83 (0.60, 1.17)   0.286

CRP, C-reactive protein; ln, log-transformed; RBP, retinol-binding protein.

Discussion {#sec4}
==========

At least one-third of the Sumedang infants, irrespective of age, had anemia, which at 9 and 12 mo nearly reached or surpassed the level indicative of a severe public health problem (i.e., \>40%) ([@bib31]). Serum ferritin ([@bib41]), after correction for inflammation, was the only biomarker that predicted Hb and risk of anemia at both 6 and 12 mo of age, highlighting the urgent need to improve the iron status of these infants during late infancy. In contrast, the contribution of nonnutritional factors as predictors of low Hb concentrations and anemia was restricted to infants at 6 mo of age. The roles of helminthic infection and genetic Hb disorders were not explored in view of the small number of cases for these 2 conditions. Reports on the prevalence of helminthic infection and genetic Hb disorders in Indonesia, especially among infants, are limited.

Earlier studies in Indonesia ([@bib2], [@bib42]) also observed that low Hb concentrations during late infancy were associated with ID (based on low serum ferritin), although none to our knowledge examined the potential role of other micronutrients known to have a role in hematopoiesis, unlike here. In this study, a similar relation between low Hb concentrations and low serum ferritin was observed, after adjusting for inflammation, at both 6 and 12 mo of age. This association was attributed, at least in part, to inadequate intakes of dietary iron in the infants at both 6 and 12 mo of age ([@bib20]). Such deficits occurred even though almost all infants at age 6 mo (91.7%) consumed iron-fortified foods ([@bib20]). However, both the amount of the iron-fortified products consumed as well as the readily available heme iron from flesh foods were low at 12 mo ([@bib20]).

Of the nonnutritional factors investigated here, inflammation based on CRP was found to predict a low Hb and be a significant independent risk factor for anemia at age 6 mo. This trend is not unexpected ([@bib43]), arising in part from disturbances in iron homeostasis in response to high concentrations of circulating hepcidin stimulated by inflammatory cytokines ([@bib44]). However, in addition to disturbances in iron homeostasis, increased hepcidin expression induced by inflammation may also contribute to impaired erythropoiesis and slightly shortened RBC survival time which, together with lower Hb, further increase the risk of anemia ([@bib45]).

At age 6 mo we also observed a negative relation between male sex and Hb, and a higher risk of anemia, a finding consistent with earlier reports in Indonesia ([@bib41]) and elsewhere ([@bib46], [@bib47]) and related to sex-related differences in growth rate ([@bib41], [@bib48], [@bib49]). Certainly, our male and taller infants had greater body weights and thus potentially higher daily requirements for iron than female/smaller infants, which may also be linked with the increased risk of anemia observed at age 6 mo among infants of taller mothers. Not surprisingly, a significant positive correlation existed between maternal height and length-for-age *z* scores of infants (*r* = 0.18; *P* = 0.007), as described elsewhere ([@bib50], [@bib51]).

Attenuation of the associations between the nonnutritional factors (inflammation and sex) and Hb for the infants by age 12 mo may be linked to the marked depletion in their iron stores at this time compared with the concentrations at age 6 mo when complementary foods first began to replace breast milk. At age 12 mo, 65% of the infants had depleted iron stores (based on ferritin \<12 µg/L) compared with only 21% at 6 mo. In New Zealand infants, iron stores (measured by serum ferritin) were a stronger predictor of anemia at age 12 mo than for infants at age 6 mo ([@bib46]). Seemingly, when iron stores are low, iron becomes the single strongest predictor of Hb after adjusting for other potential nutritional and nonnutritional factors.

Despite seeming deficiencies of vitamin A, B-12, zinc, and selenium across all ages, only vitamin A (assessed by RBP) was positively associated with Hb at age 12 mo, by which time more than two-thirds of the infants had received vitamin A supplements. This finding is not unexpected and has been described elsewhere ([@bib11], [@bib52]).

Our study has several strengths, including a longitudinal design and the collection of many variables associated with low Hb concentrations and anemia during late infancy. We examined 7 micronutrients, adjusted for inflammation where appropriate, and measured nonnutritional factors including inflammation, helminths, and selected genetic Hb disorders. However, identification of the latter among infants at age 12 mo is complicated by the possibility that HbA~2~ can rise further for the first 1--2 y of life ([@bib55]) and IDA can reduce the HbA~2~ concentration slightly ([@bib55], [@bib56]). Other biomarkers related to Hb and iron absorption, such as hepcidin and glucose-6-phosphate dehydrogenase, were also not investigated.

In conclusion, our results emphasize that anemia remains a serious public health problem during infancy in Sumedang district, Indonesia, with low iron status being a major predictor of Hb even after adjustment for several micronutrients and nonnutritional factors. Hence, there is an urgent need to re-evaluate anemia and ID control programs in the district.
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